Blinn E. Combs

BY Blinn E. Combs, Esq. and Michael Alexander, Esq., Brown & Fortunato, P.C. A trial in Eugene, Oregon, is shining a national spotlight on the state’s new first-in-nation restrictive corporate practice of medicine law. In Stapleton v.

BY Blinn E. Combs, Esq. and Michael R. Alexander, Esq., Brown & Fortunato, P.C. On June 17, 2025, a little over two months after initiating large-scale layoffs at the agency, the federal Food and Drug Administration (“FDA”) announced a new Commissioner’s National Priority Voucher (“CNPV”) program. The CNPV aimed to give voucher recipients the opportunity to shorten new drug approval timelines from 10-12 months down to 1-2 months.

BY Blinn E. Combs, Esq. and Michael R. Alexander, Esq., Brown & Fortunato, P.C. On April 1, Robert F. Kennedy, Jr., newly installed Secretary of the federal Health and Human Services Department (“HHS”) began implementing changes announced on March 27 as part of the Trump Administration’s Make America Healthy Again initiative. The press release and related fact sheet promised large-scale restructuring of the HHS and the many departments operating under it.